AVF’s newsletter written by one of C-TRACT’s investigators
In The News
NATF On-line support group – Podcast
An Update on Post-Thrombotic Syndrome – North American Thrombosis Forum
The Kinked Wire – Podcast
Episode 5: The potential of C-TRACT to help PTS patients | Guests: Suresh Vedantham and Mary Costantino – The Kinked Wire
Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial
Summary: This article, published in Thrombosis and Haemostasis, describes the clinical outcomes of pharmaco-mechanical catheter-directed thrombolysis (PCDT) in the 300-patient subgroup of the ATTRACT study with femoral-popliteal deep vein thrombosis (DVT) (without involvement of more proximal veins). Kearon, Clive; Gu, Chu-Shu; Julian, Jim; Goldhaber, Samuel; Comerota, Anthony; Gornik, Heather; Murphy, Timothy; Lewis, Laurence; Kahn, Susan; […]
Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis from a Stratified Multicenter Randomized Trial
Summary: This article, published in Circulation, describes the clinical outcomes observed in the 391-patient subgroup of ATTRACT study patients who had iliofemoral DVT (DVT involving the iliac and/or common femoral vein). Citation: Comerota, Anthony J.; Kearon, Clive; Gu, Chu-Shu; Julian, Jim A.; Goldhaber, Samuel Z.; Kahn, Susan R.; Jaff, Michael R.; Razavi, Mahmood K.; Kindzelski, […]
ATTRACT trial concludes clot-busting drugs do not prevent long-term blood clot complications for most patients
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis (ATTRACT Main Results) Summary: This article, published in the New England Journal of Medicine, describes the main results and primary outcome of the landmark ATTRACT Trial. Citation: Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis […]
Vedantham Editorial 2018
“This article, published in the European Journal of Endovascular and Vascular Surgery, contains additional perspective on the ATTRACT Trial from its lead investigator.” Vedantham EJVES ATTRACT Editorial 2018 FINAL PUBLISHED
Response Letter to NEJM Editor
“This letter, published in the New England Journal of Medicine, is the lead investigators’ response to comments on the ATTRACT Trial’s main results.” Published ATTRACT Response Letter to NEJM 5-3-18
The ATTRACT Study: Open for Patient Enrollment (Currently closed)
https://www.veindirectory.org/magazine/article/industry-updates/the-attract-study-open-for-patient-enrollmentThe ATTRACT Study: Open for Patient EnrollmentApril 1, 2015 by Suresh Vedantham, MD The ATTRACT (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis) Study, which may define the future of DVT treatment, is now OPEN to patient enrollment! This study will determine if new clot-busting treatments for patients with large blood clots of the […]
Interview with Vein Specialist Suresh Vedantham M.D.
https://www.veindirectory.org/magazine/article/featured-doctor/cover-story-vein-specialist-suresh-vedantham-m-dVein Specialist Suresh Vedantham M.D.April 1, 2015 Vein specialist Suresh Vedantham M.D., has spent most of his career studying the diagnosis and treatment of venous thromboembolism (VTE), deep-vein thrombosis (DVT) and pulmonary embolism (PE). Nearly 1 million Americans suffer from DVT, and 500,000 of them develop PE, which causes some 300,000 deaths. These conditions remain […]
Pivotal study of minimally invasive therapy improves care of DVT
https://www.sirweb.org/advocacy-and-outreach/media/news-release-archive/news-release-ATTRACT-Trial/ Pivotal study of minimally invasive therapy improves the care of patients with deep vein thrombosis NIH-sponsored ATTRACT Trial finds opportunities to reduce disability and enhance patient safety WASHINGTON (March 6, 2017)—The results of a prominent, National Institutes of Health (NIH)-sponsored study into the treatment of deep vein thrombosis (DVT) provide important guidance for physicians […]
Blood clot treatments subject of major trial
Blood clot treatments subject of major trial By Michael C. Purdy • September 24, 2008 A $10 million, government-funded, multicenter clinical trial of an aggressive treatment for blood clots in the leg — known as deep vein thrombosis (DVT) — will be led by School of Medicine researchers. About 250,000 U.S. patients are diagnosed with […]
$10M clinical trial tests new treatment for blood clots
https://www.eurekalert.org/pub_releases/2008-09/wuso-mc091208.phpPUBLIC RELEASE: 15-SEP-2008$10M clinical trial tests new treatment for blood clots in the legWASHINGTON UNIVERSITY SCHOOL OF MEDICINE St. Louis, Sept. 15, 2008 — A $10 million, government-funded, multicenter clinical trial of an aggressive treatment for blood clots in the leg known as deep vein thrombosis (DVT) will be led by researchers at Washington University […]
ATTRACT Main Results
“This article, published in the New England Journal of Medicine, describes the main results and primary outcome of the landmark ATTRACT Trial.” To view the archived PDF of the ATTRACT New England Journal of Medicine publication, please click the button below:
ATTRACT Design Paper
“This article, published in the American Heart Journal, summarizes the collaborative planning, methodology, and design of the ATTRACT Trial.” ATTRACT Design Paper